UBS Maintains a 'Buy' on Johnson & Johnson (JNJ); Management Meeting Reinforces Improving Outlook
Go back to UBS Maintains a 'Buy' on Johnson & Johnson (JNJ); Management Meeting Reinforces Improving Outlook| Johnson & Johnson (NYSE: JNJ) | Delayed: 263.40 +4.13 (1.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $259.27 | 52 Week High | $126.07 | |||
| Open | $261.43 | 52 Week Low | $94.28 | |||
| Day High | $263.71 | P/E | 54.76 | |||
| Day Low | $259.61 | EPS | $4.81 | |||
| Volume | 6,351,046 | |||||

